Enhancement of hippocampal synaptic AMPA receptor function by the antidepressant tianeptine and by opioid peptides.
Management of major depressive disorder (MDD) with conventional therapeutics that enhance monoaminergic neurotransmission requires prolonged treatment prior to clinical benefit and a substantial proportion of patients show little or no improvement. Identifying alternative molecular targets is required to develop effica...